Polymorphism of Cocrystals: The Promiscuous Behavior of Agomelatine-Reference-Cited by-同舟云学术

Polymorphism of Cocrystals: The Promiscuous Behavior of Agomelatine

Published:2016-01-08 Issue:2 Volume:16 Page:1063-1070
ISSN:1528-7483
Container-title:Crystal Growth & Design
language:en
Short-container-title:Crystal Growth & Design

Author:

Prohens Rafel¹,Barbas Rafael¹,Portell Anna¹,Font-Bardia Mercè¹,Alcobé Xavier¹,Puigjaner Cristina¹

Affiliation:

1. Unitat de Polimorfisme i Calorimetria and ‡Unitat de Difracció de Raigs X, Centres Científics i Tecnològics, Universitat de Barcelona, Baldiri Reixac 10, 08028 Barcelona, Spain

Publisher

American Chemical Society (ACS)

Subject

Condensed Matter Physics,General Materials Science,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.cgd.5b01628

Reference28 articles.

1. Facts and fictions about polymorphism

2. Diversity in Single- and Multiple-Component Crystals. The Search for and Prevalence of Polymorphs and Cocrystals

3. Polymorphism in co-crystals: a metastable form of the ionic co-crystal 2 HBz·1 NaBz crystallised by flash evaporation

4. Structure−Stability Relationships in Cocrystal Hydrates: Does the Promiscuity of Water Make Crystalline Hydrates the Nemesis of Crystal Engineering?

5. Polymorphism in cocrystals: a review and assessment of its significance

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymorphs of praziquantel–succinic acid cocrystal: Crystal structure, thermodynamic relationship, and improved pharmaceutical performance;Journal of Molecular Structure;2024-07

2. Structural Characterization of Pharmaceutical Cocrystals with the Use of Laboratory X-ray Powder Diffraction Patterns;Crystals;2023-04-09

3. Discovered two polymorphs and two solvates of lamotrigine-tolfenamic acid salt: Thermal behavior and crystal morphological differences;International Journal of Pharmaceutics;2022-11

4. Two anhydrous forms and one monohydrate of a cocrystal of axitinib and glutaric acid: characterization, property evaluation and phase transition study;CrystEngComm;2022

5. Enhancing the stability of active pharmaceutical ingredients by the cocrystal strategy;CrystEngComm;2022